Serum cystatin C has been shown to be a risk factor for CAD after the observation that cystatin C independently predicted major cardiovascular events, chronic kidney disease, and cardiovascular and all-cause mortality [22]. This evidence concerns the gene CST3 and chronic kidney disease.